XML 37 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
January 2024 P I P E Transaction
At The Market Sales Agreement
Common Stock
Common Stock
January 2024 P I P E Transaction
Common Stock
At The Market Sales Agreement
Additional Paid-In Capital
Additional Paid-In Capital
January 2024 P I P E Transaction
Additional Paid-In Capital
At The Market Sales Agreement
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023       45,177,730              
Beginning balance at Dec. 31, 2023 $ 28,931     $ 4     $ 436,060     $ 3,759 $ (410,892)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (29,584)                   (29,584)
Stock-based compensation 2,750           2,750        
Foreign currency translation 528                 528  
Issuance of common stock (in shares)         44,751,286 150,000          
Issuance of common stock   $ 52,364 $ 191   $ 4     $ 52,360 $ 191    
Conversion of tranche rights liability to equity 28,396           28,396        
Ending balance (in shares) at Mar. 31, 2024       90,079,016              
Ending balance at Mar. 31, 2024 $ 83,576     $ 8     519,757     4,287 (440,476)
Beginning balance (in shares) at Dec. 31, 2024 90,150,869     90,150,869              
Beginning balance at Dec. 31, 2024 $ 18,429     $ 8     525,611     4,209 (511,399)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (25,473)                   (25,473)
Stock-based compensation 2,042           2,042        
Foreign currency translation $ (285)                 (285)  
Ending balance (in shares) at Mar. 31, 2025 90,150,869     90,150,869              
Ending balance at Mar. 31, 2025 $ (5,287)     $ 8     $ 527,653     $ 3,924 $ (536,872)